Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Excellent Post Xtremetz
To clarify, my comments on "a buyout for a penny would only be 6.6 million" was meant to show just how undervalued the current PPS is. Your explanation in detail reinforces my attempt to show just how undervalued this company is. They have 2 strong drug plays with more in the pipeline. The 2 drugs are life changing. The sleep apnea drug would be a first available in an arena in desperate need and KRM-II-81 simply full of life changing potential at a time the world is demanding alternatives for opioids.
I agree with all you say and under a penny possibly a nickel is comical. I will continue to accumulate at these levels. These levels won't be here for long.
Ponto Ventures has been active since mid December. Probably hit the ground running beginning of 2024. Incredible findings are being published and they are moving forward. The more that is known the higher the purchase price will be. KRM-II-81 serving as an alternative to opioids for pain relief and the impressive results recently displayed for epilepsy, again shows just how undervalued the market cap truly is.
Very revealing: "KRM-II-81 has the potential to represent a breakthrough medication for pain, epilepsy, and other neuropsychiatric disorders.” Tells me there is much more to this story.
Notice the last part of that sentence: "and other neuropsychiatric disorders"
Doesn't take a rocket scientist to see the potential. I have witnessed stocks run nickels and dimes on a fraction of that type of potential with billions of O/S. Much better SS with $RSPI. A fraction of this potential merely progresses to reality your $$ PPS targets are not out of the question.
You got it brother
Lilly would be more interested buying rspi's compound into their organization, rather than go to a competitor, and while rspi is more needful of cash, Lilly might get it as cheap as ever if they move swiftly?
A larger pharma could buy out the whole company for $6.6 million/.01 per share and have the entire pipeline!
Now hopefully the company is looking for a better deal than that because it's worth much more! Minimum 25 million imho. The value of one drug.
I am just being extra conservative!
Have a great weekend all!
To Respond to Some
on the board. We only know what we have been provided in 8K's and PR's.
However, many of us know trading patterns and signs from trading activity as a result of many years of experience. I like what I see!
What we do know is that we have a very promising drug pipeline of patented/IP that has experienced some very positive results thus far and we are sitting at a dirt low Market Cap.
We also know the company is actively seeking to achieve (funding, partnerships, or sale). The SS is strong, and the trade is strong.
I know what I think. I will let the rest of the investors on this board come to their own conclusion.
Have a great 3-day weekend!
Adding Here
I agree the more bashers the better! Nate finalizes this we go UP. Getting close.
What podcast brother...
Heck I am game!
In Theory...
6.6 million buys the entire pipeline for a .01 penny!
I believe that's why Pinto Ventures is on board ultimately to get more pennies (Funding Partnership, or Sale) Some of Will Clodfelter's compensation was shares valued at .0015. He has incentive to make bank on this as well👍️
The first big move was the strategy for the sleep apnea drug. The way I take this they were doing this the arrangement with RsolutionRX was specific for the sleep apnea drug to establish valuation and for funding the completion of the project. There were specific benefits etc. in Australia in the form of tax incentives etc. ResolutionRx Ltd (Australian Company Number a/k/a ACN 664 925 651) was formed in Australia on 11th January 2023 by RespireRx as an unlisted public company. The company was formed by RespireRX.
Funding, partnership, or sale. Remember those are the 3 being sought after right now.
Nice List 👍️
RSPI Market cap is $613,263
Is working on Revolutionary New Hope:
KRM-II-81 Drug-Resistant Epilepsy Patients
Huge growth potential👍️
Absolutely oldstocks
RGBP had 3.5 billion O/S when it ran to .07 cents in 3 days.
The SS is incredibly strong to go along with an incredibly strong pipeline of drugs and their patented/IP! Crazy LOW MC.
Undervalued PHARMA's are the way to go in this crazy OTC today.They can leave the pink sheets quickly👍️
Shares Getting Soaked Up...
Soon if not already, this won't be just a IHUB crowd loading shares. There will be larger players, outside the HUB, loading as many shares as they can.
The word is getting out on this one, bet on it.
Just Reviewing...
ENZC 45.8 million market cap
$RSPI 877,083 market cap
52.2 times larger. ENZC market cap would put $RSPI at PPS .0783 👍️
Just something to think about.
I agree DTGoody
All the pieces are falling into place. The big step forward was mid December getting the help they needed to take this to the next level. Ponto Ventures!
This isn't just an investment anymore. This is about lives being saved and quality of life across the entire neuropsychiatric spectrum.
Opioids are killing people daily. Epilepsy is a devastating brain disorder. KRM-II-81 is showing very positive results in multiple spectrums.
RespireRx could be a Game/Life Changer! So far, the evidence is showing just that.
Just excited to be a part of life changing/enhancing solutions in its infancy👍️
From an investment perspective I agree completely DTGoody.
The moves: Ponto Ventures, Debt Restructure, Sleep apnea strategy, focusing on (funding, partnerships, or sale), all the strategy pieces are falling into place! I agree when it gets going there will be NO looking back!
BUY and HOLD for me! Great Investment (Feels good about something REAL and HELPING FOLKS) and also the financial reward potential.
Excellent News!!👍️
Patience. We will have delayed moves when we least expect it👍️
Sitting at a MC of 818,000 this is a huge gift at these prices. When they are ready to let it go or even PUSH it up it will be fast and furious! Attention getting focused on KRM-II-81. This truly moves the needle medically speaking across the board as a huge solution to society and many needing help. Major impacts.
Nice Volume
Just a matter of time!
Value in the pipeline and patents! Good Pharma stocks will uplist once they break through.
Multiple drugs can have breakout moments here.
Glad to be on board!👍️
Hey Brother..
Your DD caused me to give this a look. I am great full. Don’t you go anywhere. Post anytime you want. I’ve got your back here. I’m sure others do too. 👍
Of course it can..
The stock is undervalued! Not a typical otc pinky. This stock has all the potential for an uplist. Dirt cheap market cap!
Incredible patented/ip pipeline!!
Comical Reality
A larger pharma could buyout $RSPI
$5.8 million .01 PPS
$11.6 million .02 PPS
Thats petty cash for larger pharma's in this day and age!
Any funding/partnership 5-10 million we would go much higher with future potential.
Just a matter of time!👍️
IP/Patents worth much more imho!
Goes to show how undervalued we are today!
Loaded with Potential👍️
Patience is going to be rewarded🔥 It can happen at any time!
DTGoody thanks for the I-Box updates! $RSPI
Nice Reversal!
Stick with the fundamentals!👍️
We Derive Wisdom from Experience/Trials!
Earning it the hard way at times!
I am HOLDING $RSPI TIGHT and ADDING CHEAPIES!
Always ready to fuel the fire when BIG NEWS HITS!
Overjoyed to be on Board
Hobbes Great DD!
Have to reply Jaxxm. CBIA is a A/S increasing, REG-A diluter. Don't even mention that with this A/S reducing, 12 million annual revenues generating, no note, no debt, 2 million cash in bank, need I go on? Diamond in the ruff! You might just want to buy in here.
Sorry brother.
I will go back to being quiet! 👍️
Funny Thing
This is about the time and scenario I unloaded my RGBP, 2 days before it ran to .07+ cents from these levels. 😂😂😂
I had an amazing run so far in other holdings, so it didn't hurt too bad, but it sure did sting some 😀. Mercy did I miss out.
NOT MISSING THE BIG RUN HERE! It's coming. I see pharma minimum 25 million for less. We have value of 25 million for the apnea drug alone! Sitting at a paltry Market Cap of 760,129. These shares today were steals!👍️
Glad to be here!
Even the Best and Undervalued of Pharma ....
have their share of board pestilence spewing senseless nonsense!
Now $RSPI is more undervalued with the same pipeline of drugs and patented IP! 👍️
Triggers weak hands to be frightened out of their shares and strong hands opportunities to buy cheap shares!
Added today thank you very much👍️ Possibly some notes clearing as well.
Added Shares!
Getting absorbed at these levels!
Just My Opinion About KRM-II-81💎
The Diamond 💎 in the Ruff! Life Changer/ Game Changer 💎
Just because it isn't discussed on our message board on IHUB, you can rest assured it is being discussed in Pharma boardrooms where it truly matters!
Investors will come from outside IHUB. After that AI generated information and the PR with the comment and designation "GROUND BREAKING, a REAL GAME CHANGER" was given to KRM-II-81 it turned up on many a radar!
BET ON IT!!!
Chasers
Lots going on in the OTC. Sell low to buy high. Folks always searching for something else when they are already in a potential LIFE CHANGER!
May not be easy to get back into this Crown Jewel! All I can say, I did that with RGBP. I didn't sell to chase but I sold. Hadn't performed my DD thorough enough.
A few days later, from levels close to where RSPI is today, it went to .07+ cents.
Don't Underestimate the Value of Fridays Restructure
It represents confidence where this company is headed with their drug pipeline:
1) Management's desire to keep excess shares out of the market
2) Management anticipates paying these off within the year. The terms are very favorable.
3) A reason for this. The anticipation of impactful material event(s) on the way.
4) Anyone previously discounting the value of the company just had their eyes opened. If you were shorting the stock anticipating a major increase to the O/S on 1-31-2024 to cover and was wondering where they were, the recent restructure damped those expectations. Those are Not Happening!
5) Most importantly management and Ponto Ventures are busy growing a potential pharma juggernaut (investment(funding), partnering, or sale) on the way.
I added shares on this dip today. They are LOCKED away for safe keeping!👍️
Essentially
ResolutionRx(R&D focus only) and RespireRx have the same CEO and management.
First off, I am no expert with these types of transactions. The way I take this they were doing this specific for the sleep apnea drug to establish valuation and for funding the completion of the project. There were specific benefits etc. in Australia in the form of tax incentives etc. ResolutionRx Ltd (Australian Company Number a/k/a ACN 664 925 651) was formed in Australia on 11th January 2023 by RespireRx as an unlisted public company. The company was formed by RespireRX.
What I liked was: "which assumes 90% of a US$25 million maximum value for the net assets provided by RespireRx to ResolutionRx and is subject to adjustment downward, but not upward, based upon the result of the independent valuation." This is the value given TODAY. There is much more to this POSITIVE than meets the eye folks imho!
They placed a 25-million-dollar maximum value for essentially the IP/patent for the (sleep apnea drug alone). Easily why we see this as a vastly undervalued stock with a market cap in the 900,000 range for all the drugs.
Again, I am no expert, but I also see how $RSPI has been trading. Something POSITIVE and potentially BIG is coming imho.
I agree BIO.....
I was reading the paragraphs and keyed in on the exact paragraph you are focused in on. I did this, before reading your messages. We are on the same page.
“I am very excited about working with Will,” said Jeff Margolis, the Company’s Senior Vice President, Chief Financial Officer, Treasurer and Secretary. “His involvement adds considerable depth and experience to our financial and business activities being conducted to set up our programs for investment, partnering or sale While his initial efforts will focus on the ResolutionRx dronabinol program, I am certain that his efforts will also extend to our other programs.”
Ponto Ventures has been involved since Mid December 2023. You can bet wheels are rolling and irons in the fire.
Our current Market Cap: 1,052,487 as of 02-02-2024
One of the three material events are going to happen: investment(funding), partnering, or sale. The current Market Cap and the position the company is in right now, makes $RSPI one of if not the most undervalued OTC Pharma stock out there today imho. Not by just a few million dollars either.
I have witnessed pharma's run from our current levels to pennies and silver in days.
When one of the 3 material events noted hits, even for just one drug, RespireRx will be discussing uplist to a higher exchange imho.
Even before any one of the 3 are announced I can see $RSPI begin to creep up based on what we know today. Two drugs alone are displaying positive results. It wouldn't surprise me one bit to see copper before any announcement. We have investors still accumulating. This could run out of the blue even on a day there is no news. It's a game of chicken. Folks are buying trying to avoid any massive uptick. Bottom line for some to get the positions they want. They are going to have to get aggressive and buy their way in on the ask, even if it takes it to .005 or even copper. I believe at those levels it will still be undervalued. imho
Awesome to be on board!👍️
You Got That Right BIO!
OTC has so many boring stocks, this one has that juggernaut potential.
Patience!
Uniqueness of Pharma
I would judge to say most of your stocks that break out of the OTC pink markets to larger exchanges are the pharma's that have life changing IP patented drugs. These are the game and life changers for investors and folks needing help.
RespireRx has documented game breaking results. Larger pharma is being made aware of these advancements. Ponto Ventures took on RespireRx for their potential in the pipeline. It's just a matter of time funding/partnerships start kicking in.
Larger pharma is anxiously looking for the next big drug. Sorry it doesn't get any bigger than "KRM-II-81 Totally Suppressed Epileptiform Activity in Brain Tissue Surgically Removed from Epileptic Patient".
The sleep apnea market is in desperate need of solutions. Now that the face masks are being attached to cancer the need grows even more.
Patience will be rewarded imho!
Glad to be here!
Getting Ready!
My bet they are getting advice probably from our new addition Mr. Clodfelter from Ponto Ventures.
Funding/Partnership you can bet is on the way and a path to trials!
Higher PPS on conversions tells me they are getting ready to see some movement.
Get all this stuff cleared up so when it's time to move it moves with no resistance!
Just a gut feel. I haven't read anything yet. Just your post Zino!👍️
GM All!!
Tied up in office this morning. Need to see what's going on!
We all know its just a matter of time regardless! UNDERVALUED!
GM All !!
Another day closer! Undervalued special Pharma play!
Patience.
Sleep Apnea and Epilepsy ground breaking drugs in their pipeline among many others.
Patents/IP worth 10's of millions+ today sitting at 1,110,959.
I Agree ...
Already the case with how KRM-II drug helped the epilepsy patient.
In my opinion that was major huge. Definitely drew the attention of more eyes to the stock. It could very well have a delayed run because of that. However, there are those wanting their shares too. The recent small dilution is being gobbled up.
The powers that be that control this were not ready to move it. We will know when we have that 100+ million share day.
$RSPI has in place a truly undervalued patented/IP drug pipeline.
This will explode as either a delayed reaction to the sleep apnea and KRM-II drug or possibly when we get funding/partnership news.
Thats where Ponto Ventures comes in. They have been engaged since Mid December 2023.
Patience...
There's More Interest than you think.
This stock lack of interests
You say you like their business? Then let the DD make your call. You can wait for a 100 million share day and buy in. Oops you wont get it at this PPS. LOL
This is a strategic under the radar pharma play. I have seen pharma's which billions o/s jump from this level to a nickel in no time. Whatever floats your boat!
Patience is my strategy and buying dips! I will fuel the ask when a game changing material event hits. 👍️
$RSPI's Need Grows
Interesting...https://www.dailymail.co.uk/health/article-13023713/Phillips-halt-sales-sleep-apnea-machines-cancer.html
Growing need for the sleep apnea drug to get formulated/tested and rapidly approved. The need is ever growing!
Regarding the sleep apnea machines, that is a bad deal. I know a couple folks that use the machines.
Bottom Line: We have a sleeping giant here. imho
OTC typical pink investors
OTC has no patience anymore, especially with companies with meat. Bid sits will turn to ask slaps, just a waiting game. Would like to fast forward a little, and reap the fruits of our labor. $$$
have no patience. Just a few out there see the big picture. Honestly 95% of OTC pinks are scams. Pharma can attract investors interested in being on the ground floor of something special and have the right mindset and patience to take advantage of it. This stock has the potential to leave IHUBBERS behind. Not bad mouthing us for being on IHUB but you understand my drift.
The investors we want are NOT IHUB.
Patience!!!
GM!!
Glad to be here! Incredible company with solutions that will provide help to many suffering folks!
Vastly Undervalued! Word is getting out.
One spark will ignite the engines. Pharma's tanks are filled with rocket fuel.
Under the Radar
Not For Long. More investors are getting on board quietly.
Juggernaut Pharma in the making imho! They are undervalued and have the drugs, IP, and Patents!
$RSPI
Patience. You can feel the strength!
One Material Event
We have all witnessed crazy Pharma moves. Nature of the sector. Undervalued Pharma, dirt low market cap, strong pipeline, one partnership/funding for one of the patented drugs, we all know what happens.
Glad to be here and see my dollars invested in a company trying to make a positive difference in folk's lives. The epilepsy results simply amaze me!